Avadel Pharmaceuticals PLC (AVDL) Financials

$21.64

$0.00 (0.00%)

As on 13-Feb-2026 09:30EDT

Market cap

$2,124 Mln

Revenue (TTM)

$249 Mln

P/E Ratio

--

P/B Ratio

21.6

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Operating Revenue	248.52	169.12	27.96	1.50	--	22.33
Cost of Revenue	13.75	15.28	0.85	1.49	0.82	5.74
Gross Profit	234.76	153.84	27.12	-1.49	-0.82	16.59
Operating Expenses	230.24	196.24	164.97	98.56	85.55	10.78
Operating Profit (EBIT)	4.52	-42.40	-137.85	-98.56	-85.55	5.82
Other Income	--	--	--	--	2.13	-1.27
Profit before Tax	-3.26	-49.08	-160.78	-111.44	-93.15	-5.08
Provision for Tax	-2.98	-0.25	-0.50	26.03	-15.82	-12.11
Profit after Tax (Net Income)	-0.28	-48.83	-160.28	-137.46	-77.33	7.03
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	-137.46	-77.33	7.03

Liabilities ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Shareholder's Funds	98.23	73.85	87.74	-21.15	78.24	162.27
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	38.74	41.55	40.10	98.14	148.02	134.26
Current Liabilities	62.49	48.83	36.86	55.79	21.00	15.11
Total Liabilities	261.94	164.24	164.70	132.79	247.27	311.64

Assets ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Non-Current Assets	27.22	30.03	30.50	31.94	54.78	48.18
Current Assets	172.23	134.21	134.20	100.84	192.49	263.45
Total Assets	261.94	164.24	164.70	132.79	247.27	311.64
Total Debt*	37.38	1.70	2.62	131.02	145.00	130.52
Net Current Assets	109.74	85.37	97.35	45.05	171.49	248.35

Cashflow ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	--	-46.91	-128.51	-70.30	-77.31	-48.73
Cash Flow from Investing Activities	--	51.78	-50.09	79.70	56.93	-69.72
Cash from Financing Activities	--	15.97	135.34	14.54	0.26	179.68
Net Cash Inflow / Outflow	--	--	--	--	-20.12	61.23

Financials Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Adjusted EPS ($)	-0.01	-0.51	-1.87	-2.17	-1.32	0.12
Cash EPS ($)	--	-0.48	-1.84	-2.15	-1.31	0.15
Adjusted Book Value ($)	--	0.77	1.02	--	1.33	2.78
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.49	-1.50	-1.11	-1.32	-0.84
Free Cash Flow per Share ($)	--	-0.49	-1.50	-1.12	-1.32	-0.84

Profitability Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
ROCE (%)	--	-58.86	-160.08	-82.53	-29.97	3.62
ROE (%)	-0.32	-60.44	-481.35	-481.49	-64.30	10.56
ROA (%)	-0.12	-29.69	-107.75	-72.34	-27.67	3.04
EBIT Margin (%)	2.60	-22.62	-539.61	-6,624.13	--	35.43
Net Margin (%)	-0.11	-28.87	-573.17	-9,188.77	-3,637.30	33.36
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	79.88	5.05	17.69	--	-1.00	-0.62
EBIT Growth (%)	110.33	74.65	-52.27	-19.10	-1,151.61	130.32
Net Profit Growth (%)	99.62	69.53	-16.59	-77.77	-1,200.30	121.15
EPS Growth (%)	99.31	0.73	0.14	-0.65	-11.95	1.14
Book Value Growth (%)	25.09	--	--	--	--	--

Valuation Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Price / Earnings	--	-20.75	-7.57	-3.29	-6.13	55.44
Price / Book Value	21.62	13.72	13.83	-21.41	6.05	2.40
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	200.89	-26.46	-7.45	-4.99	-5.60	31.11
Close Price ($)	15.27	10.51	14.12	7.16	8.08	6.68
High Price ($)	16.66	19.09	16.85	10.02	11.59	13.49
Low Price ($)	6.38	9.41	6.35	1.05	6.35	4.00
Market Cap ($ Cr)	2,124.00	--	--	--	--	--

Solvency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debt to Equity	--	0.02	0.03	-6.20	1.85	0.80
Short term debt to equity ratio	0.01	0.01	0.01	-1.83	0.01	0.00
Current Ratio	2.76	2.75	3.64	1.81	9.17	17.44
Quick Ratio	2.37	2.33	3.36	1.81	--	17.44
Interest Coverage	0.66	-3.53	-15.26	-8.03	-8.37	0.61

Operating Efficiency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	17.08	20.16	43.28	150.27	--	173.65
Asset Turnover	1.07	1.03	0.19	0.01	--	0.10
Receivable days	--	49.89	93.73	4,124.69	--	415.04
Inventory Days	--	366.73	2,240.72	--	--	113.54
Payable days	--	224.27	4,171.23	1,904.41	2,378.16	287.33
Cash Conversion Cycle	--	192.35	-1,836.79	2,220.28	--	241.26

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.